Enzymotec to Report Fourth Quarter and Full Year 2015 Financial Results
February 03 2016 - 7:30AM
Enzymotec Ltd. (NASDAQ:ENZY), a developer, manufacturer and
marketer of innovative bio-active lipid ingredients and medical
foods, today announced that the Company will release financial
results for the fourth quarter and full year ended December 31,
2015 on Wednesday, February 17, 2016, before the market opens.
Following the release, Dr. Ariel Katz, President and Chief
Executive Officer, and Oren Bryan, Vice President and Chief
Financial Officer, will host a conference call to review the
financial results.
The conference call is scheduled to begin at 8:30 a.m. ET on
Wednesday, February 17, 2016. Participants should dial (877)
359-9508 (United States) or (224) 357-2393 (International) with
confirmation code 42574817 to access the live call. The call
will also be broadcast live over the Internet, hosted in the
Investors section of Enzymotec's website
at http://edge.media-server.com/m/p/nznghg4j, and will be
archived online within one hour of its completion through February
24, 2016.
About Enzymotec Ltd.Enzymotec Ltd. is a leading
global supplier of specialty lipid-based products and solutions.
The Company develops, manufactures and markets innovative
bio-active lipid ingredients, as well as final products, based on
sophisticated processes and technologies. For more information,
visit www.enzymotec.com.
CONTACT:
The Ruth Group
Tram Bui / Lee Roth
(646) 536-7035/7012
tbui@theruthgroup.com
lroth@theruthgroup.com
ENZYMOTEC LTD. (NASDAQ:ENZY)
Historical Stock Chart
From Jun 2024 to Jul 2024
ENZYMOTEC LTD. (NASDAQ:ENZY)
Historical Stock Chart
From Jul 2023 to Jul 2024
Real-Time news about Enzymotec Ltd. - Ordinary Shares (delisted) (NASDAQ): 0 recent articles
More News Articles